-
1
-
-
45249109128
-
Sibutramine-associated adverse effects: A practical guide for its safe use
-
DOI 10.1111/j.1467-789X.2007.00425.x
-
Florentin M, Liberopoulos EN, Elisaf MS. Sibutramineassociated adverse effects: a practical guide for its safe use. Obes Rev 2008;9:378-387. (Pubitemid 351842191)
-
(2008)
Obesity Reviews
, vol.9
, Issue.4
, pp. 378-387
-
-
Florentin, M.1
Liberopoulos, E.N.2
Elisaf, M.S.3
-
2
-
-
0032434821
-
Sibutramine. A review of its contribution to the management of obesity
-
DOI 10.2165/00003495-199856060-00019
-
McNeely W, Goa KL. Sibutramine. A review of its contribution to the management of obesity. Drugs 1998;56: 1093-1124. (Pubitemid 29010230)
-
(1998)
Drugs
, vol.56
, Issue.6
, pp. 1093-1124
-
-
McNeely, W.1
Goa, K.L.2
-
3
-
-
0042134607
-
Severe bullous drug eruption due to sibutramine (Reductil®) [14]
-
DOI 10.1046/j.1365-2133.2003.05413.x
-
Goh BK, Ng PP, Giam YC. Severe bullous drug eruption due to sibutramine (Reductil). Br J Dermatol 2003;149:215-216. (Pubitemid 36966548)
-
(2003)
British Journal of Dermatology
, vol.149
, Issue.1
, pp. 215-216
-
-
Goh, B.K.1
Ng, P.P.L.2
Giam, Y.C.3
-
4
-
-
33644825973
-
Cutaneous vasculitis update: Diagnostic criteria, classification, epidemiology, etiology, pathogenesis, evaluation and prognosis
-
DOI 10.1097/01.dad.0000181109.54532.c5, PII 0000037220051200000007
-
Carlson JA, Ng BT, Chen KR. Cutaneous vasculitis update: diagnostic criteria, classification, epidemiology, etiology, pathogenesis, evaluation and prognosis. Am J Dermatopathol 2005;27:504-528. (Pubitemid 44383995)
-
(2005)
American Journal of Dermatopathology
, vol.27
, Issue.6
, pp. 504-528
-
-
Carlson, J.A.1
Ng, B.T.2
Chen, K.-R.3
-
5
-
-
0021920254
-
Clinical and histopathologic spectrum of necrotizing vasculitis. Report of findings in 101 cases
-
DOI 10.1001/archderm.121.2.220
-
Sanchez NP, Van Hale HM, Su WP. Clinical and histopathologic spectrum of necrotizing vasculitis. Report of findings in 101 cases. Arch Dermatol 1985;121:220-224. (Pubitemid 15162714)
-
(1985)
Archives of Dermatology
, vol.121
, Issue.2
, pp. 220-224
-
-
Sanchez, N.P.1
Van Hale, H.M.2
Su, W.P.D.3
-
6
-
-
7444224288
-
Cutaneous reactions to drugs
-
In: Woff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, editors. 7th ed. New York: McGraw Hill
-
Shear NH, Knowles SR, Shapiro L. Cutaneous reactions to drugs. In: Woff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, editors. Fitzpatrick's dermatology in general medicine. 7th ed. New York: McGraw Hill, 2007:360-361.
-
(2007)
Fitzpatrick's Dermatology in General Medicine.
, pp. 360-361
-
-
Shear, N.H.1
Knowles, S.R.2
Shapiro, L.3
-
7
-
-
33244482014
-
Tissue eosinophilia as an indicator of drug-induced cutaneous small-vessel vasculitis
-
DOI 10.1001/archderm.142.2.155
-
Bahrami S, Malone JC, Webb KG, Callen JP. Tissue eosinophilia as an indicator of drug-induced cutaneous small-vessel vasculitis. Arch Dermatol 2006;142:155-161. (Pubitemid 43276527)
-
(2006)
Archives of Dermatology
, vol.142
, Issue.2
, pp. 155-161
-
-
Bahrami, S.1
Malone, J.C.2
Webb, K.G.3
Callen, J.P.4
-
8
-
-
68949206690
-
Cutaneous necrotizing venulitis
-
In: Woff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, editors. 7th ed. New York: McGraw Hill
-
Soter NA, Jose L, Perez D. Cutaneous necrotizing venulitis. In: Woff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, editors. Fitzpatrick's dermatology in general medicine. 7th ed. New York: McGraw Hill, 2007:1599-1606.
-
(2007)
Fitzpatrick's Dermatology in General Medicine
, pp. 1599-1606
-
-
Soter, N.A.1
Jose, L.2
Perez, D.3
-
9
-
-
0029092455
-
Urticarial vasculitis induced by fluoxetine
-
Roger D, Rollé F, Mausset J, Lavignac C, Bonnetblanc JM. Urticarial vasculitis induced by fluoxetine. Dermatology 1995;191:164.
-
(1995)
Dermatology
, vol.191
, pp. 164
-
-
Roger, D.1
Rollé, F.2
Mausset, J.3
Lavignac, C.4
Bonnetblanc, J.M.5
-
10
-
-
34547793160
-
Urticarial vasculitis secondary to paroxetine
-
Welsh JP, Cusack CA, Ko C. Urticarial vasculitis secondary to paroxetine. J Drugs Dermatol 2006;5:1012-1014.
-
(2006)
J Drugs Dermatol
, vol.5
, pp. 1012-1014
-
-
Welsh, J.P.1
Cusack, C.A.2
Ko, C.3
-
11
-
-
33748768480
-
Cutaneous vasculitis during selective serotonin reuptake inhibitor therapy
-
DOI 10.1016/j.amjmed.2006.03.031, PII S0002934306005080
-
Flores-Suárez LF, Vega-Memije ME, Chanussot-Deprez C. Cutaneous vasculitis during selective serotonin reuptake inhibitor therapy. Am J Med 2006;119:e1-e3. (Pubitemid 44415615)
-
(2006)
American Journal of Medicine
, vol.119
, Issue.10
-
-
Flores-Suarez, L.F.1
Vega-Memije, M.E.2
Chanussot-Deprez, C.3
-
13
-
-
34147099029
-
Cutaneous effects of the most commonly used antidepressant medication, the selective serotonin reuptake inhibitors
-
DOI 10.1016/j.jaad.2006.10.020, PII S0190962206028507
-
Krasowska D, Szymanek M, Schwartz RA, My?li?ski W. Cutaneous effects of the most commonly used antidepressant medication, the selective serotonin reuptake inhibitors. J Am Acad Dermatol 2007;56:848-853. (Pubitemid 46560997)
-
(2007)
Journal of the American Academy of Dermatology
, vol.56
, Issue.5
, pp. 848-853
-
-
Krasowska, D.1
Szymanek, M.2
Schwartz, R.A.3
Myslinski, W.4
|